Page 12 - Berkeley Light News Today

Agreement debuts Berkeley Lights' rapid high-throughput functional screening capability to accelerate and expand the discovery and development of Bayer Crop Science's seeds and traits product pipelineEMERYVILLE

EMERYVILLE, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the release of its TechAccess Subscription model to enable

Berkeley Lights Announces Opto™ Assure For Early Manufacturability Assessment of Antibody Therapeutics EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the launch of Opto Assure, a series of assays that provides yield and product quality data at an earlier stage in cell line development. The first of the series enables direct detection of product aggregates, ensuring a faster ramp toward volume pro...

25 febbraio 2021 16:47 Fonte: Adnkronos #salute-e-benessere BOSTON, Feb. 25, 2021 /PRNewswire/ -- Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system. The new instrument, developed by Berkeley Lights, will support the expansion of Biocytogens antibody discovery service platform in the greater Boston area for collaborations across the globe. Founded on its successful gene editing platform, Biocytogen ...

Biopharma Manufacturers Shouldn’t Rush When “Going Digital” Digitizing manufacturing activities requires strong management and a stepwise approach to implementations [SolStock/Getty Images] Share Digitization is a hot topic in biopharma. In recent years, AstraZeneca, Novartis, and Sanofi have each unveiled plans to use data to link drug development, manufacturing, and distribution, citing speed and efficiency as motivation for the investments. These investments show biopharma is...